Inside the Lab

Although molecular testing offers promising opportunities for diagnosis and targeted treatment of cancers, prostate cancer has lagged behind other types of cancer. Recently, homologous recombination repair testing in prostate cancer has provided a means to achieving targeted treatments for patients as well as opening new avenues of collaboration between pathologists and oncologists

As CRC affects younger and more diverse populations, emerging tests for CRC biomarkers provide enormous utility for diagnosis. However, misdiagnosis of CRC, shifting demographics of those afflicted with CRC, and patient unfamiliarity with symptoms create challenges in identifying CRC. In this episode of Inside the Lab, hosts Dr. Ali Brown and Lotte Mulder are joined by Dr. Melissa

Recent developments in disease modifying therapies have been proven to slow the progression of cognitive decline associated with Alzheimer’s disease. And yet, we can only confirm a diagnosis of AD after a patient’s death. But what if we could use biomarkers to identify preclinical stage Alzheimer’s and step in long before a patient exhibits dementia? On this episode of Inside

The availability of targeted therapies has changed the landscape of cancer treatment in the last few years. And two types of cancer particularly affected by these advances are melanoma and non-small cell lung carcinoma or NSCLC. What role does the laboratory play in the diagnosis and treatment of these cancers? How can pathologists and lab professionals work with oncologists to opt

Tests that are designed in-house to fulfill a clinical need (but aren’t FDA approved) qualify as laboratory developed tests. And these LDTs are currently regulated by CLIA. But the FDA is proposing a new rule that would give them oversight of the design and development of laboratory developed tests. So, what does that mean for us? How would this new legislation impact everyday pr

Working on the bench can feel like being in a black box. And as important as it is to advocate for patients, pathologists and laboratory professionals rarely have direct access to them. So, what can we do to encourage patient-centered care in the medical laboratory? On this episode of Inside the Lab, your hosts, Ms. Kelly Swails, MLS(ASCP), and Dr. Lotte Mulder, PhD, are joined by

We know that diverse teams perform better. In laboratory medicine, diversity, equity, and inclusion in leadership not only inspires young professionals, it also promotes retention in a profession that struggles with staffing shortages. So, what’s stopping us from increasing representation and equity in laboratory leadership? What can we do to recruit a more diverse pool of job ap

Would you benefit from having a mentor to help you grow as a pathologist or laboratory professional? How might you benefit from becoming a mentor yourself? We get further, faster, with support, and having the right mentor accelerates your personal and professional development. But how do you find a good mentor? And what can you do to make the mentor-mentee relationship successful?

What inspires a doctor to pursue pathology? Dr. Elvio Silva, MD, was drawn to pathology because it’s the only specialty in medicine where you can SEE the disease. And his patient-centered approach to studying tumors has led to breakthrough research. On this episode of Inside the Lab, Dr. Silva, Professor in the Department of Pathology at MD Anderson Cancer Center, joins our hosts

Are you dreaming of moving up the ladder and transitioning to a management position in the laboratory? Or maybe even a leadership role outside the lab? What can you do to learn the leadership skills you need to take that next step in your career? On this episode of Inside the Lab, your hosts, Ms. Kelly Swails, MLS(ASCP), and Dr. Lotte Mulder, PhD, are joined by Dr. Gary Procop, MD,